COMMUNIQUÉS West-GlobeNewswire

Eve & Co Enters Into Supply Agreement With Newfoundland Labrador Liquor Corporation; Represents Third Provincial Supply Agreement
18/09/2018
TORONTO, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Eve & Co Incorporated (the “Company” or “Eve”) (TSXV: EVE) is pleased to announce that, through its wholly-owned subsidiary Natural MedCo Ltd., it has entered into an [...]
Zomedica Pharmaceuticals Corp. to Present at LD Micro NYC Summit and Cantor 2018 Global Healthcare Conference
18/09/2018
ANN ARBOR, Mich., Sept. 18, 2018 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary diagnostic and pharmaceutical company, today announced that it [...]
Loxo Oncology Announces Accepted Abstracts at the 88th Annual Meeting of the American Thyroid Association
18/09/2018
STAMFORD, Conn., Sept. 18, 2018 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical company developing highly selective medicines for patients with genomically defined cancers, today announced [...]
ChromaDex and Dartmouth College File Patent Infringement Lawsuit Against Elysium Health
18/09/2018
IRVINE, Calif., Sept. 18, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an integrated, science-based, nutraceutical company devoted to improving the way people age with its flagship ingredient NIAGEN® and [...]
HEXO Bolsters Management Team, Appoints Two New VPs
18/09/2018
GATINEAU, Quebec, Sept. 18, 2018 (GLOBE NEWSWIRE) -- HEXO Corp. (“HEXO” or the “Company”) (TSX:HEXO) is pleased to announce that it has bolstered its leadership team by appointing Nick Davies as Vice-President of [...]
HEXO renforce son équipe de direction avec la nomination de deux vice-présidents
18/09/2018
GATINEAU, Québec, 18 sept. 2018 (GLOBE NEWSWIRE) -- HEXO Corp. (« HEXO » ou la « Société ») a le plaisir d’annoncer le renforcement de son équipe de direction avec la nomination de Nick Davies au poste de vice-président [...]
A new study comparing TK 210™ ELISA from AroCell with other activity-based assays for the measurement of TK1 in serum shows high correlation between methods when samples from subjects with hematological malignancies are compared. The study
18/09/2018
An abstract entitled “A performance evaluation of three currently used thymidine kinase 1 assays in sera from patients with hematological malignancies shows high concordance” , by Staffan Eriksson et al., has been [...]
Transactions in relation to share buyback program
18/09/2018
Acting under its share buyback authorization, the GN Store Nord Board of Directors initiated a share buyback program on May 2, 2018, in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]
Update regarding the Market Authorization Application of Apealea in the European Union
18/09/2018
With reference to yesterday’s communicated agenda for this week’s meeting by the Committee for Medicinal Products for Human Use (CHMP), the European Medicines Agency (EMA) has informed Oasmia Pharmaceutical that no oral [...]
Solon Eiendom ASA – Primary insider notification
18/09/2018
(Oslo, Norway, September 17, 2018) Solon Eiendom ASA Board Member Tore Aksel Voldberg has today through his wholly owned company Skøien AS bought 15.000 shares in Solon Eiendom ASA at a price of NOK 29.16. Following [...]
Shire plc: Rule 2.9 Announcement
18/09/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 18 September 2018 [...]
Annonucement no. 7/2018 - Coloplast Capital Markets Day 2018
18/09/2018
Announcement No. 7/2018 18 September 2018 Coloplast Capital Markets Day 2018 Coloplast is hosting a Capital Markets Day in Humlebæk today at 8:15 local time. The purpose of this event is to provide institutional [...]
VIFOR PHARMA GROUP INCREASES EQUITY INVESTMENT IN CHEMOCENTRYX
18/09/2018
Vifor Pharma Group increases equity stake in ChemoCentryx from 6.6% to 21.2%. Vifor Pharma Group acquires an additional 7,343,492 common shares of ChemoCentryx, Inc. (NASDAQ: CCXI) from GlaxoSmithKline - an additional [...]
Orphazyme to Present at InvestorDagen 2018
18/09/2018
Orphazyme A/S Investor news No. 10/2018 Company Registration No. 32266355 Copenhagen, September 18, 2018 – Orphazyme A/S , a biopharmaceutical company dedicated to developing treatments for patients living with rare [...]
Philippe Ugnat, LLB joins VANC Pharmaceuticals Inc. as Stratregic Advisor
18/09/2018
VANCOUVER, British Columbia, Sept. 17, 2018 (GLOBE NEWSWIRE) -- VANC Pharmaceuticals Inc. (“VANC” or the “Company”) is pleased to announce the appointment of Philippe Ugnat as Strategic Advisor to help drive the [...]
WHILL, Inc. Raises $45 Million In Funding
18/09/2018
Accelerating global expansion and to fund MaaS business growth SAN CARLOS, Calif., Sept. 17, 2018 (GLOBE NEWSWIRE) -- WHILL, Inc., the innovative company behind the award-winning, next-generation Personal Electric [...]
MPX Provides Update on GreenMart of Nevada NLV LLC
18/09/2018
TORONTO, Sept. 17, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (“ MPX ” or the “ Company ”) (CSE: MPX; OTC: MPXEF) today provided a short update on its GreenMart of Nevada NLV, LLC (“ GreenMart NV ”) operations [...]
Osiris Therapeutics, Inc. Announces GrafixPL PRIME™ Launches October 1, 2018
17/09/2018
COLUMBIA, Md., Sept. 17, 2018 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (NASDAQ: OSIR), a regenerative medicine company focused on developing and marketing products for wound care, orthopedics, and sports medicine, [...]
World's largest Alzheimer's survey reveals most adults believe a cure will be developed in their lifetime
17/09/2018
From a sample of over 10,000 adults, 62% are worried that they may develop Alzheimer's disease and 91% believe the solution to tackling diseases lies in medical research[1] 79% are willing to take part in medical [...]

Pages